Aurobindo Pharma (AUROPHARMA) — Announcement

📢 Key Event
Aurobindo Pharma to attend Elara India Dialogue investor meeting

💡 Investor Takeaway
Retail investors can directly engage with management during scheduled one-on-one meetings.

Aurobindo Pharma announced its participation in the Ashwamedh – Elara India Dialogue 2026 investor meeting on September 1, 2026, in Mumbai, offering one-on-one and group sessions with company officials. The filing confirms no unpublished price sensitive information will be discussed during the event. This provides retail investors a direct channel to engage with management ahead of potential strategic updates.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AUROPHARMA ✨ Ask AI About This

About Aurobindo Pharma Limited (AUROPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹97,238.86 Cr P/E: 26.4 ROE: 9.8% ROCE: 12.8% Div Yield: 0.24%

View full AUROPHARMA stock details →

📡 Get AI alerts when AUROPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AUROPHARMA — Free

💡 Ask AI about this filing

"When will Aurobindo Pharma share strategic updates?" "What is the company's revenue growth outlook?" "How does Aurobindo Pharma compare to peers on margins?"

Ask AI Free →

📊 More AUROPHARMA filings

See all AUROPHARMA filings →

🔥 Also filed on 25 August 2026

EPL EPL Limited Annual Report AMANTA Amanta Healthcare Limited Annual Report ZEEL Zee Entertainment Enterprises Limited Annual Report FINKURVE Finkurve Financial Services Limited Corporate Action EPL EPL Limited Annual Report ARVIND Arvind Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AUROPHARMA files new disclosures

Track AUROPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AUROPHARMA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd